Abstract
This evidence-based review is a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (AAN). Using the AAN criteria for the classification of evidence, the authors reviewed the literature on “the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of adult and childhood spasticity.” For the treatment of spasticity in adults, they found 14 Class I trials (11 for upper- and 3 for lower-extremity spasticity), most of which showed that BoNT reduced …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
